Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Open-market buy President and CEO bought 500 shares at an average $2.50 ($1,251)
  2. 4 Open-market buy Chief Financial Officer bought 1,600 shares at $2.56 ($4,102)
  3. 4 Open-market buy President and CEO bought 400 shares at $2.52 ($1,008)
  4. 4 Open-market buy Director bought 2,000 shares at $2.53 ($5,060)
  5. 4 Open-market buy President and CEO bought 300 shares at $2.55 ($765)
  6. 4 Open-market buy President and CEO bought 3,850 shares at an average $2.36 ($9,080)
  7. 4 Open-market buy Chief Financial Officer bought 500 shares at $2.64 ($1,318)
  8. 4 Open-market buy Director bought 1,000 shares at $2.70 ($2,700)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
  16. 4/A Open-market buy Director bought 5,000 shares at $1.50 ($7,500)
  17. 4 Open-market buy Chief Financial Officer bought 2,850 shares at $2.45 ($6,988)
  18. 4 Open-market buy Director bought 1,000 shares at $2.43 ($2,430)
  19. 4 Open-market buy President and CEO bought 1,100 shares at an average $1.74 ($1,914)
  20. 4 Open-market buy President and CEO bought 700 shares at an average $1.65 ($1,154)

Page 15 of 23 · 442 filings